2022 Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander, Olle Stål (2022) Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study Frontiers in Oncology, Vol. 12 Vidare till DOI Ylva Naeser, Hildur Helgadottir, Johan Hansson, Christian Ingvar, Nils Elander, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Antonios Valachis, Dimitrios Papantoniou, Agneta Nordin Danfors, Hemming Johansson, Anders Sundin, Yvonne Brandberg, Gustav J. Ullenhag (2022) Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study) Cancers, Vol. 14 Vidare till DOI 2021 Jenny Isaksson, Henrik Green, Dimitrios Papantoniou, Linn Pettersson, Mats Anden, Johan Rosell, Elisabeth Åvall Lundqvist, Nils Elander (2021) Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer World Journal of Clinical Oncology, Vol. 12, s. 1009-1022 Vidare till DOI Karen Aughton, Nils Elander, Anthony Evans, Richard Jackson, Fiona Campbell, Eithne Costello, Christopher M. Halloran, John R. Mackey, Andrew G. Scarfe, Juan W. Valle, Ross Carter, David Cunningham, Niall C. Tebbutt, David Goldstein, Jennifer Shannon, Bengt Glimelius, Thilo Hackert, Richard M. Charnley, Alan Anthoney, Markus M. Lerch, Julia Mayerle, Daniel H. Palmer, Markus W. Buechler, Paula Ghaneh, John P. Neoptolemos, William Greenhalf (2021) hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA Cancers, Vol. 13 Vidare till DOI Hakon Blomstrand, Atul Batra, Winson Y. Cheung, Nils Elander (2021) Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer World Journal of Clinical Oncology, Vol. 12, s. 787-799 Vidare till DOI
Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander, Olle Stål (2022) Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study Frontiers in Oncology, Vol. 12 Vidare till DOI
Ylva Naeser, Hildur Helgadottir, Johan Hansson, Christian Ingvar, Nils Elander, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Antonios Valachis, Dimitrios Papantoniou, Agneta Nordin Danfors, Hemming Johansson, Anders Sundin, Yvonne Brandberg, Gustav J. Ullenhag (2022) Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study) Cancers, Vol. 14 Vidare till DOI
Jenny Isaksson, Henrik Green, Dimitrios Papantoniou, Linn Pettersson, Mats Anden, Johan Rosell, Elisabeth Åvall Lundqvist, Nils Elander (2021) Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer World Journal of Clinical Oncology, Vol. 12, s. 1009-1022 Vidare till DOI
Karen Aughton, Nils Elander, Anthony Evans, Richard Jackson, Fiona Campbell, Eithne Costello, Christopher M. Halloran, John R. Mackey, Andrew G. Scarfe, Juan W. Valle, Ross Carter, David Cunningham, Niall C. Tebbutt, David Goldstein, Jennifer Shannon, Bengt Glimelius, Thilo Hackert, Richard M. Charnley, Alan Anthoney, Markus M. Lerch, Julia Mayerle, Daniel H. Palmer, Markus W. Buechler, Paula Ghaneh, John P. Neoptolemos, William Greenhalf (2021) hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA Cancers, Vol. 13 Vidare till DOI
Hakon Blomstrand, Atul Batra, Winson Y. Cheung, Nils Elander (2021) Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer World Journal of Clinical Oncology, Vol. 12, s. 787-799 Vidare till DOI